216 related articles for article (PubMed ID: 15102883)
1. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.
Ikewaki K; Cain W; Thomas F; Shamburek R; Zech LA; Usher D; Brewer HB; Rader DJ
J Lipid Res; 2004 Jul; 45(7):1302-11. PubMed ID: 15102883
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
3. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes.
Parhofer KG; Hugh P; Barrett R; Bier DM; Schonfeld G
J Lipid Res; 1991 Aug; 32(8):1311-23. PubMed ID: 1770313
[TBL] [Abstract][Full Text] [Related]
4. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
5. ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.
Hinsdale ME; Sullivan PM; Mezdour H; Maeda N
J Lipid Res; 2002 Sep; 43(9):1520-8. PubMed ID: 12235184
[TBL] [Abstract][Full Text] [Related]
6. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
[TBL] [Abstract][Full Text] [Related]
8. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
Dinkel RE; Barrett PH; Demant T; Parhofer KG
Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
[TBL] [Abstract][Full Text] [Related]
9. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):881-8. PubMed ID: 9157951
[TBL] [Abstract][Full Text] [Related]
10. ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B).
Yang CY; Xie YH; Yang M; Quion JA; Gotto AM
J Protein Chem; 1995 Oct; 14(7):503-9. PubMed ID: 8561846
[TBL] [Abstract][Full Text] [Related]
11. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
[TBL] [Abstract][Full Text] [Related]
12. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans.
Demant T; Seeberg K; Bedynek A; Seidel D
Atherosclerosis; 2001 Aug; 157(2):325-39. PubMed ID: 11472732
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
[TBL] [Abstract][Full Text] [Related]
15. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
Millar JS; Lichtenstein AH; Cuchel M; Dolnikowski GG; Hachey DL; Cohn JS; Schaefer EJ
J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
[TBL] [Abstract][Full Text] [Related]
16. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
[TBL] [Abstract][Full Text] [Related]
17. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
18. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
van Vlijmen BJ; Mensink RP; van 't Hof HB; Offermans RF; Hofker MH; Havekes LM
J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
